Detalhe da pesquisa
1.
Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial.
PLoS Med
; 21(2): e1004356, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38377166
2.
Handling intercurrent events and missing data in non-inferiority trials using the estimand framework: A tuberculosis case study.
Clin Trials
; 20(5): 497-506, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37277978
3.
Rethinking intercurrent events in defining estimands for tuberculosis trials.
Clin Trials
; 19(5): 522-533, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35850542
4.
Economic evaluation of short treatment for multidrug-resistant tuberculosis, Ethiopia and South Africa: the STREAM trial.
Bull World Health Organ
; 98(5): 306-314, 2020 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32514196
5.
Rethinking non-inferiority: a practical trial design for optimising treatment duration.
Clin Trials
; 15(5): 477-488, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29871495
6.
Testing many treatments within a single protocol over 10 years at MRC Clinical Trials Unit at UCL: Multi-arm, multi-stage platform, umbrella and basket protocols.
Clin Trials
; 14(5): 451-461, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28830236
7.
Estimands for clinical endpoints in Tuberculosis treatment randomized controlled trials: a retrospective application in a completed trial.
Res Sq
; 2023 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37986887
8.
Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment.
Lancet Respir Med
; 1(6): 462-70, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24429244